Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer

被引:48
|
作者
Wirtenberger, Michael
Frank, Bernd
Hemminki, Kari
Klaes, Ruediger
Schmutzler, Rita K.
Wappenschmidt, Barbara
Meindl, Alfons
Kiechle, Marion
Arnold, Norbert
Weber, Bernhard H. F.
Niederacher, Dieter
Bartram, Claus R.
Burwinkel, Barbara
机构
[1] German Canc Res Ctr, DKFZ, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany
[2] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden
[3] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany
[4] Univ Hosp Cologne, CMMC, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany
[5] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-8000 Munich, Germany
[6] Univ Hosp Schleswig Holstein, Dept Obstet & Gynaecol, Div Oncol, Kiel, Germany
[7] Univ Regensburg, Inst Human Genet, D-8400 Regensburg, Germany
[8] Univ Dusseldorf, Ctr Clin, Dept Obstet & Gynaecol, Div Mol Genet, Dusseldorf, Germany
[9] Helmholtz Univ, Grp Mol Epidemiol, DKFZ, Heidelberg, Germany
关键词
D O I
10.1093/carcin/bgi374
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations of the human RecQ helicase genes WRN and BLM lead to rare autosomal recessive disorders, Werner and Bloom syndromes, which are associated with premature ageing and cancer predisposition. We tested the hypothesis whether three polymorphic, non-conservative amino acid exchanges in WRN and BLM act as low-penetrance familial breast cancer risk factors. Moreover, we examined the putative impact of p53 MspI 1798G > A, which is completely linked to p53PIN3, a 16 bp insertion/duplication that has been associated with reduced p53 expression, on familial breast cancer risk. Genotyping analyses, performed on 816 BRCA1/2 mutation-negative German familial breast cancer patients and 1012 German controls, revealed a significant association of the WRN Cys1367Arg polymorphism with familial breast cancer (OR = 1.28, 95% CI 1.06-1.54) and high-risk familial breast cancer (OR = 1.32, 95 % CI 1.06-1.65). The analysis of p53 MspI 1798G > A, which is completely linked to p53PIN3, showed a significantly increased familial breast cancer risk for carriers of the 16 bp insertion/duplication, following a recessive mode (OR = 2.15, 95% CI = 1.124.11). WRN Cys1367Arg, located in the C-terminus, the binding site of p53, is predicted to be damaging. The joint effect of WRN Cys1367Arg and p53 MspI resulted in an increased breast cancer risk compared to the single polymorphisms (OR = 3.39, 95% CI 1.19-9.71). In conclusion, our study indicates the importance of inherited variants in the WRN and p53 genes for familial breast cancer susceptibility.
引用
收藏
页码:1655 / 1660
页数:6
相关论文
共 50 条
  • [41] The estrogen receptor regulates the transcription of p53 target genes in breast cancer cells
    Bailey, Shannon T.
    Shin, Hyunjin
    Liu, X. Shirley
    Brown, Myles
    CANCER RESEARCH, 2012, 72
  • [42] The p53 network: p53 and its downstream genes
    Shu, Kun-Xian
    Li, Biao
    Wu, Li-Xiang
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 55 (01) : 10 - 18
  • [43] Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
    Amr Ghaleb
    Alisha Yallowitz
    Natalia Marchenko
    Communications Biology, 2
  • [44] Irradiation induces p53 loss of heterozygosity in breast cancer expressing mutant p53
    Ghaleb, Amr
    Yallowitz, Alisha
    Marchenko, Natalia
    COMMUNICATIONS BIOLOGY, 2019, 2 (01)
  • [45] Interaction between p53 staining and high-dose chemotherapy in breast cancer
    Lonning, PE
    Borresen-Dale, AL
    CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2289 - 2289
  • [46] p53 autoantibodies in sera of breast cancer patients: Association with p53 gene mutations and p53 protein overexpression.
    Angelopoulou, K
    Yu, H
    Diamandis, EP
    CLINICAL CHEMISTRY, 1997, 43 : 770 - 770
  • [47] A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency
    Kato, Hisaya
    Maezawa, Yoshiro
    Nishijima, Dai
    Iwamoto, Eisuke
    Takeda, June
    Kanamori, Takashi
    Yamaga, Masaya
    Mishina, Tatsuzo
    Takeda, Yusuke
    Izumi, Shintaro
    Hino, Yutaro
    Nishi, Hiroyuki
    Ishiko, Jun
    Takeuchi, Masahiro
    Kaneko, Hiyori
    Koshizaka, Masaya
    Mimura, Naoya
    Kuzuya, Masafumi
    Sakaida, Emiko
    Takemoto, Minoru
    Shiraishi, Yuichi
    Miyano, Satoru
    Ogawa, Seishi
    Iwama, Atsushi
    Sanada, Masashi
    Yokote, Koutaro
    EXPERIMENTAL HEMATOLOGY, 2022, 109 : 11 - 17
  • [48] p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer
    Angelopoulou, K
    Yu, H
    Bharaj, B
    Giai, M
    Diamandis, EP
    CLINICAL BIOCHEMISTRY, 2000, 33 (01) : 53 - 62
  • [49] P53 codon 72 polymorphism in breast cancer
    Buyru, N
    Tigli, H
    Dalay, N
    ONCOLOGY REPORTS, 2003, 10 (03) : 711 - 714
  • [50] p53 Expression in Young Women with Breast Cancer
    Finkelman, Brian
    Pincus, Jennifer
    Siziopikou, K. P.
    Blanco, Luis
    LABORATORY INVESTIGATION, 2019, 99